Cenestin and lipid metabolism disorder Patient Reports February 11, 2012

Cenestin Side Effects Report #5348249-8
Cenestin side effect was reported by a Consumer or non-health professional from JAPAN on May 21, 2007. Female patient, 40 years of age, was diagnosed with oestradiol decreased and was treated with Cenestin. After drug was administered, patient experienced the following side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to liver, metastases to lymph nodes, suprapubic pain, vaginal haemorrhage. Cenestin dosage: 0.625 MG. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE. Patient died.

Cenestin Side Effects Report #5379575-4
Cenestin side effect was reported by a Consumer or non-health professional from JAPAN on May 21, 2007. Female patient, 40 years of age, was diagnosed with oestradiol decreased and was treated with Cenestin. After drug was administered, patient experienced the following side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to abdominal cavity, metastases to liver, metastases to lymph nodes. Cenestin dosage: 0.625 MG. During the same period patient was treated with MEDROXYPROGESTERONE. Patient died.